149 related articles for article (PubMed ID: 31564902)
1. STAT gene family mRNA expression and prognostic value in hepatocellular carcinoma.
Dong Z; Chen Y; Yang C; Zhang M; Chen A; Yang J; Huang Y
Onco Targets Ther; 2019; 12():7175-7191. PubMed ID: 31564902
[TBL] [Abstract][Full Text] [Related]
2. Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
Wang X; Liao X; Yu T; Gong Y; Zhang L; Huang J; Yang C; Han C; Yu L; Zhu G; Qin W; Liu Z; Zhou X; Liu J; Han Q; Peng T
Int J Oncol; 2019 Oct; 55(4):805-822. PubMed ID: 31485610
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics Analysis of Expression Profiles and Prognostic Values of the Signal Transducer and Activator of Transcription Family Genes in Glioma.
Ji W; Liu Y; Xu B; Mei J; Cheng C; Xiao Y; Yang K; Huang W; Jiao J; Liu H; Shao J
Front Genet; 2021; 12():625234. PubMed ID: 34276757
[TBL] [Abstract][Full Text] [Related]
4. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of key genes of the JAK-STAT signaling pathway in patients with cutaneous melanoma.
Pan F; Wang Q; Li S; Huang R; Wang X; Liao X; Mo H; Zhang L; Zhou X
Oncol Lett; 2020 Mar; 19(3):1928-1946. PubMed ID: 32194688
[TBL] [Abstract][Full Text] [Related]
6. Mining the prognostic significance and immune infiltration of
Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
[TBL] [Abstract][Full Text] [Related]
7. Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma.
Chen Q; Li F; Gao Y; Xu G; Liang L; Xu J
Front Oncol; 2020; 10():1210. PubMed ID: 32903581
[TBL] [Abstract][Full Text] [Related]
8. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
[TBL] [Abstract][Full Text] [Related]
9. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Liu GM; Zeng HD; Zhang CY; Xu JW
Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Lipid Metabolism Genes as Diagnostic and Prognostic Indicators in Hepatocellular Carcinoma.
Li X; Tan Y; Liu B; Guo H; Zhou Y; Yuan J; Wang F
Curr Genomics; 2023 Oct; 24(2):110-127. PubMed ID: 37994323
[TBL] [Abstract][Full Text] [Related]
11. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
[TBL] [Abstract][Full Text] [Related]
12. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
PeerJ; 2019; 7():e7816. PubMed ID: 31608178
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
14. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
15. A pan-cancer analysis of the expression of STAT family genes in tumors and their relationship to the tumor microenvironment.
Zhou M; Zhang P; Da M; Yang R; Ma Y; Zhao J; Ma T; Xia J; Shen G; Chen Y; Chen D
Front Oncol; 2022; 12():925537. PubMed ID: 36176415
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Xiong C; Wang G; Bai D
Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma.
Lin H; Zhang R; Wu W; Lei L
Cancer Genet; 2020 Jul; 245():27-34. PubMed ID: 32559715
[TBL] [Abstract][Full Text] [Related]
18. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
[TBL] [Abstract][Full Text] [Related]
19.
Gao Y; Li Y; Song Z; Jin Z; Li X; Yuan C
J Oncol; 2022; 2022():6509028. PubMed ID: 35847356
[TBL] [Abstract][Full Text] [Related]
20. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
